[{"id":"a688087c-68be-4853-9780-49620057e35d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04517851","created_at":"2021-01-18T21:38:49.784Z","updated_at":"2025-02-25T15:26:29.899Z","phase":"Phase 2","brief_title":"Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis","source_id_and_acronym":"NCT04517851","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" JAK2 • IL1R1 • SLAMF7","pipe":" | ","alterations":" JAK2 V617F","tags":["JAK2 • IL1R1 • SLAMF7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JAK2 V617F"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Empliciti (elotuzumab)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 02/10/2021","start_date":" 02/10/2021","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2025-02-10"},{"id":"dc3869b4-fd2e-4860-99c7-096db7913cb2","acronym":"","url":"https://clinicaltrials.gov/study/NCT05836688","created_at":"2023-05-01T14:03:54.344Z","updated_at":"2024-07-02T16:35:11.661Z","phase":"","brief_title":"A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors","source_id_and_acronym":"NCT05836688","lead_sponsor":"University of California, Irvine","biomarkers":" IL6 • TNFA • IL1R1 • CRP","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL1R1 • CRP"],"overall_status":"Recruiting","enrollment":" Enrollment 250","initiation":"Initiation: 11/01/2023","start_date":" 11/01/2023","primary_txt":" Primary completion: 07/01/2028","primary_completion_date":" 07/01/2028","study_txt":" Completion: 07/01/2028","study_completion_date":" 07/01/2028","last_update_posted":"2024-04-03"},{"id":"398611ec-32d5-4767-9ab0-d167a02f0c96","acronym":"ICE","url":"https://clinicaltrials.gov/study/NCT05727813","created_at":"2023-02-14T18:02:36.078Z","updated_at":"2024-07-02T16:35:55.606Z","phase":"","brief_title":"To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)","source_id_and_acronym":"NCT05727813 - ICE","lead_sponsor":"University of Roma La Sapienza","biomarkers":" IL6 • CXCL8 • IL2RA • CXCL9 • IL10 • HMGB1 • CCL11 • CCL2 • IL17A • CCL3 • IL13 • IL15 • IL1R1 • IL4 • IL5 • IL7","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL2RA • CXCL9 • IL10 • HMGB1 • CCL11 • CCL2 • IL17A • CCL3 • IL13 • IL15 • IL1R1 • IL4 • IL5 • IL7"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 01/16/2023","primary_completion_date":" 01/16/2023","study_txt":" Completion: 01/27/2023","study_completion_date":" 01/27/2023","last_update_posted":"2023-02-14"},{"id":"b61b36ed-ff52-451e-a650-5e97ce622140","acronym":"NL77292.056.21","url":"https://clinicaltrials.gov/study/NCT05303480","created_at":"2022-03-31T18:53:01.830Z","updated_at":"2024-07-02T16:35:57.111Z","phase":"","brief_title":"Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides","source_id_and_acronym":"NCT05303480 - NL77292.056.21","lead_sponsor":"Centre for Human Drug Research, Netherlands","biomarkers":" PD-L1 • CD8 • CXCL8 • CD4 • CCL20 • IL1A • CCL27 • IL13 • IL1R1 • IL4","pipe":"","alterations":" ","tags":["PD-L1 • CD8 • CXCL8 • CD4 • CCL20 • IL1A • CCL27 • IL13 • IL1R1 • IL4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Valchlor (mechlorethamine gel)"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 12/07/2021","start_date":" 12/07/2021","primary_txt":" Primary completion: 12/08/2022","primary_completion_date":" 12/08/2022","study_txt":" Completion: 12/08/2022","study_completion_date":" 12/08/2022","last_update_posted":"2023-01-24"},{"id":"4cdca706-931e-4c68-8e1f-a028059fe810","acronym":"","url":"https://clinicaltrials.gov/study/NCT00631852","created_at":"2021-01-18T02:21:00.868Z","updated_at":"2024-07-02T16:36:20.839Z","phase":"Phase 2","brief_title":"A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer","source_id_and_acronym":"NCT00631852","lead_sponsor":"Southern Illinois University","biomarkers":" IL6 • HGF • TNFA • CXCL8 • IL2 • IL10 • TGFB1 • IL23A • IL1B • IL1R1 • IL4 • LEP","pipe":"","alterations":" ","tags":["IL6 • HGF • TNFA • CXCL8 • IL2 • IL10 • TGFB1 • IL23A • IL1B • IL1R1 • IL4 • LEP"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 02/01/2008","start_date":" 02/01/2008","primary_txt":" Primary completion: 06/30/2019","primary_completion_date":" 06/30/2019","study_txt":" Completion: 06/30/2019","study_completion_date":" 06/30/2019","last_update_posted":"2021-11-11"},{"id":"cd1ff0d0-0d27-47af-98e6-5c1372f50799","acronym":"","url":"https://clinicaltrials.gov/study/NCT03167359","created_at":"2021-01-18T15:37:01.212Z","updated_at":"2024-07-02T16:36:30.601Z","phase":"","brief_title":"Hypofractionated Radiotherapy in Breast Cancer","source_id_and_acronym":"NCT03167359","lead_sponsor":"Emory University","biomarkers":" IL6 • TNFA • IL1R1 • CRP","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL1R1 • CRP"],"overall_status":"Completed","enrollment":" Enrollment 74","initiation":"Initiation: 12/01/2010","start_date":" 12/01/2010","primary_txt":" Primary completion: 05/14/2019","primary_completion_date":" 05/14/2019","study_txt":" Completion: 05/14/2019","study_completion_date":" 05/14/2019","last_update_posted":"2021-05-07"},{"id":"eca9d723-14f8-4867-92c8-f1445b8b46b5","acronym":"","url":"https://clinicaltrials.gov/study/NCT04150848","created_at":"2021-01-18T20:14:48.770Z","updated_at":"2024-07-02T16:36:37.108Z","phase":"Phase 2","brief_title":"A Biobehavioral Intervention for Young Men With Testicular Cancer","source_id_and_acronym":"NCT04150848","lead_sponsor":"University of California, Irvine","biomarkers":" IL6 • TNFA • IL1R1","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL1R1"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 11/01/2018","start_date":" 11/01/2018","primary_txt":" Primary completion: 11/01/2021","primary_completion_date":" 11/01/2021","study_txt":" Completion: 12/01/2021","study_completion_date":" 12/01/2021","last_update_posted":"2020-12-19"},{"id":"ac25eb02-bf93-4e16-b261-6440c672966d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01740323","created_at":"2021-01-18T07:37:00.468Z","updated_at":"2024-07-02T16:36:55.557Z","phase":"Phase 2","brief_title":"Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy","source_id_and_acronym":"NCT01740323","lead_sponsor":"Andrew H Miller","biomarkers":" IL6 • TNFA • IL1R1 • CRP","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL1R1 • CRP"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"Initiation: 05/01/2015","start_date":" 05/01/2015","primary_txt":" Primary completion: 07/27/2018","primary_completion_date":" 07/27/2018","study_txt":" Completion: 07/27/2018","study_completion_date":" 07/27/2018","last_update_posted":"2019-09-18"},{"id":"686a1d8f-18f0-46ad-8ca2-03150889547f","acronym":"","url":"https://clinicaltrials.gov/study/NCT01833884","created_at":"2021-01-18T08:09:46.527Z","updated_at":"2024-07-02T16:37:19.687Z","phase":"","brief_title":"Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic","source_id_and_acronym":"NCT01833884","lead_sponsor":"Centre Henri Becquerel","biomarkers":" IL6 • TNFRSF1A • IL1R1","pipe":"","alterations":" ","tags":["IL6 • TNFRSF1A • IL1R1"],"overall_status":"Completed","enrollment":" Enrollment 50","initiation":"Initiation: 04/01/2010","start_date":" 04/01/2010","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":" Completion: 06/01/2016","study_completion_date":" 06/01/2016","last_update_posted":"2017-07-21"},{"id":"f32764a6-1f65-43c1-921b-352e20bd0fe7","acronym":"","url":"https://clinicaltrials.gov/study/NCT00565305","created_at":"2021-01-18T02:03:39.539Z","updated_at":"2024-07-02T16:37:24.380Z","phase":"","brief_title":"Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment","source_id_and_acronym":"NCT00565305","lead_sponsor":"University of Iowa","biomarkers":" IL1R1","pipe":"","alterations":" ","tags":["IL1R1"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 07/01/2003","start_date":" 07/01/2003","primary_txt":" Primary completion: 06/01/2008","primary_completion_date":" 06/01/2008","study_txt":" Completion: 11/01/2009","study_completion_date":" 11/01/2009","last_update_posted":"2017-03-15"}]